|
|
|
Insider
Information: |
Braunstein Douglas L |
Relationship: |
|
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
3,704,541 |
|
Indirect Shares
|
35,908,536 |
|
|
Direct
Value |
$102,754,216 |
|
|
Indirect Value
|
$615,883,681 |
|
|
Total
Shares |
39,613,077 |
|
|
Total
Value |
$718,637,896 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
9
|
1
|
Stock
price went up :
|
3
|
1
|
Stock
price went down : |
6
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
-41.0%
|
14.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
JP Morgan Chase & Co |
JPM |
Chief Financial Officer |
2012-12-26 |
470,836 |
2012-12-26 |
109,479 |
Premium* |
|
Eagle Pharmaceuticals, Inc. |
EGRX |
Director |
|
0 |
2019-10-25 |
732,777 |
Premium* |
|
Corindus Vascular Robotics, Inc. |
CVRS |
Director |
2019-10-29 |
0 |
2019-10-29 |
0 |
Premium* |
|
Cardtronics Inc |
CATM |
10% Owner |
2018-02-21 |
0 |
2021-03-09 |
8,658,920 |
Premium* |
|
Cantaloupe Inc |
CTLP |
10% Owner |
2023-02-21 |
20,212 |
2023-02-21 |
9,270,694 |
Premium* |
|
Tivity Health Inc |
TVTY |
10% Owner |
|
0 |
2020-05-07 |
4,795,310 |
Premium* |
|
Talkspace, Inc |
TALK |
|
2024-03-01 |
3,213,493 |
2024-03-01 |
12,341,356 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
91 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
JPM |
JP Morgan Chase & Co |
Chief Financial Officer |
|
2012-12-21 |
4 |
GD |
$0.00 |
$0 |
I/I |
24,000 |
0 |
0 |
- |
|
CVRS |
Corindus Vascular Robotic... |
Director |
|
2019-10-29 |
4 |
D |
$4.28 |
$454,617 |
D/D |
(106,219) |
0 |
0 |
- |
|
CVRS |
Corindus Vascular Robotic... |
Director |
|
2019-10-29 |
4 |
D |
$4.28 |
$60,928,133 |
I/I |
(14,235,545) |
0 |
0 |
- |
|
TALK |
Talkspace, Inc |
Director |
|
2021-06-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,300,000) |
0 |
0 |
- |
|
JPM |
JP Morgan Chase & Co |
Chief Financial OfficerOfficer |
|
2010-06-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
456 |
|
- |
|
CVRS |
Corindus Vascular Robotic... |
Director |
|
2018-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
6,780 |
6,780 |
0 |
- |
|
CVRS |
Corindus Vascular Robotic... |
Director |
|
2018-04-06 |
4 |
A |
$1.36 |
$888 |
D/D |
653 |
7,433 |
0 |
- |
|
CATM |
Cardtronics Inc |
10% Owner |
|
2021-03-09 |
4 |
OE |
$0.00 |
$0 |
I/I |
5,952 |
14,040 |
0 |
- |
|
JPM |
JP Morgan Chase & Co |
Chief Financial Officer |
|
2012-12-17 |
4 |
GA |
$0.00 |
$0 |
I/I |
24,000 |
24,000 |
0 |
- |
|
JPM |
JP Morgan Chase & Co |
Chief Financial Officer |
|
2012-12-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
24,000 |
24,000 |
0 |
- |
|
CTLP |
Cantaloupe Inc |
10% Owner |
|
2021-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
9,606 |
25,015 |
0 |
- |
|
CVRS |
Corindus Vascular Robotic... |
Director |
|
2018-05-31 |
4 |
A |
$0.75 |
$40,000 |
D/D |
53,326 |
60,759 |
0 |
- |
|
CVRS |
Corindus Vascular Robotic... |
Director |
|
2018-07-09 |
4 |
A |
$1.17 |
$4,999 |
D/D |
4,273 |
65,032 |
0 |
- |
|
CVRS |
Corindus Vascular Robotic... |
Director |
|
2018-10-05 |
4 |
A |
$1.25 |
$4,000 |
D/D |
3,200 |
68,232 |
0 |
- |
|
CVRS |
Corindus Vascular Robotic... |
Director |
|
2019-01-08 |
4 |
A |
$1.12 |
$6,000 |
D/D |
5,357 |
73,589 |
0 |
- |
|
CVRS |
Corindus Vascular Robotic... |
Director |
|
2019-04-05 |
4 |
A |
$2.12 |
$4,999 |
D/D |
2,358 |
75,947 |
0 |
- |
|
CVRS |
Corindus Vascular Robotic... |
Director |
|
2019-05-03 |
4 |
A |
$2.17 |
$59,998 |
D/D |
27,649 |
103,596 |
0 |
- |
|
CVRS |
Corindus Vascular Robotic... |
Director |
|
2019-07-08 |
4 |
A |
$3.44 |
$4,998 |
D/D |
1,453 |
105,049 |
0 |
- |
|
CVRS |
Corindus Vascular Robotic... |
Director |
|
2019-10-07 |
4 |
A |
$4.27 |
$4,996 |
D/D |
1,170 |
106,219 |
0 |
- |
|
JPM |
JP Morgan Chase & Co |
Chief Financial Officer |
|
2012-12-26 |
4 |
GA |
$0.00 |
$0 |
I/I |
109,000 |
109,000 |
0 |
- |
|
JPM |
JP Morgan Chase & Co |
Chief Financial Officer |
|
2012-12-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
109,000 |
470,836 |
0 |
- |
|
JPM |
JP Morgan Chase & Co |
Chief Financial Officer |
|
2012-12-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
24,000 |
579,836 |
0 |
- |
|
JPM |
JP Morgan Chase & Co |
Chief Financial Officer |
|
2011-01-13 |
4 |
D |
$44.57 |
$6,773,125 |
D/D |
(151,966) |
695,985 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
Director |
|
2019-10-25 |
4 |
AS |
$63.57 |
$981,302 |
I/I |
(15,437) |
732,777 |
0 |
- |
|
EGRX |
Eagle Pharmaceuticals, In... |
Director |
|
2019-10-24 |
4 |
AS |
$62.53 |
$93,412 |
I/I |
(1,494) |
748,214 |
0 |
- |
|
91 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|